SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-163668
Filing Date
2021-05-17
Accepted
2021-05-17 16:09:07
Documents
74
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d134827d10q.htm   iXBRL 10-Q 1143995
2 EX-4.1 d134827dex41.htm EX-4.1 61204
3 EX-10.1 d134827dex101.htm EX-10.1 299499
4 EX-31.1 d134827dex311.htm EX-31.1 11407
5 EX-31.2 d134827dex312.htm EX-31.2 11268
6 EX-32.1 d134827dex321.htm EX-32.1 4215
7 EX-32.2 d134827dex322.htm EX-32.2 4234
  Complete submission text file 0001193125-21-163668.txt   6446163

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA fstx-20210331.xsd EX-101.SCH 50643
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fstx-20210331_cal.xml EX-101.CAL 42411
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fstx-20210331_def.xml EX-101.DEF 255201
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE fstx-20210331_lab.xml EX-101.LAB 443388
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fstx-20210331_pre.xml EX-101.PRE 371022
13 EXTRACTED XBRL INSTANCE DOCUMENT d134827d10q_htm.xml XML 880378
Mailing Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT
Business Address 35 PARKWOOD DRIVE BABRAHAM RESEARCH CAMPUS CAMBRIDGE X0 CB22 3AT 44 1223 497400
F-star Therapeutics, Inc. (Filer) CIK: 0001566373 (see all company filings)

IRS No.: 522386345 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37718 | Film No.: 21930571
SIC: 2834 Pharmaceutical Preparations